“Tralokinumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis in Patients Aged 12 years and Older With and Without Atopic Comorbidities” (2024) SKIN The Journal of Cutaneous Medicine, 8(1), p. s322. doi:10.25251/skin.8.supp.322.